Abstract

Cell shape and cell-envelope integrity of bacteria are determined by the peptidoglycan cell wall. In rod-shaped Escherichia coli, two conserved sets of machinery are essential for cell-wall insertion in the cylindrical part of the cell: the Rod complex and the class-A penicillin-binding proteins (aPBPs). While the Rod complex governs rod-like cell shape, aPBP function is less well understood. aPBPs were previously hypothesized to either work in concert with the Rod complex or to independently repair cell-wall defects. First, we demonstrate through modulation of enzyme levels that aPBPs do not contribute to rod-like cell shape but are required for mechanical stability, supporting their independent activity. By combining measurements of cell-wall stiffness, cell-wall insertion, and PBP1b motion at the single-molecule level we then present evidence that PBP1b, the major aPBP, contributes to cell-wall integrity by repairing cell wall defects.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files or deposited on Dryad. Source data files have been provided for Figures 1-4.Dryad datasets:Tracking data Tracking.zip: https://doi.org/10.5061/dryad.m37pvmcxq.SDS-Page raw images: https://doi.org/10.5061/dryad.9s4mw6mb9

The following data sets were generated

Article and author information

Author details

  1. Antoine Vigouroux

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Baptiste Cordier

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Andrey Aristov

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Laura Alvarez

    Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  5. Gizem Özbaykal

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Thibault Chaze

    Proteomics Platform, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Enno Rainer Oldewurtel

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Mariette Matondo

    Proteomics Platform, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Felipe Cava

    Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden
    Competing interests
    The authors declare that no competing interests exist.
  10. David Bikard

    Synthetic Biology Laboratory, Institut Pasteur, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Sven van Teeffelen

    Microbial Morphogenesis and Growth Laboratory, Institut Pasteur, Paris, France
    For correspondence
    sven.vanteeffelen@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0877-1294

Funding

H2020 European Research Council (679980)

  • Sven van Teeffelen

Agence Nationale de la Recherche (ANR-10-LABX-62-IBEID)

  • Antoine Vigouroux
  • David Bikard
  • Sven van Teeffelen

Volkswagen Foundation

  • Sven van Teeffelen

Mairie de Paris (Emergence(s))

  • Sven van Teeffelen

H2020 European Research Council (677823)

  • David Bikard

Knut och Alice Wallenbergs Stiftelse

  • Felipe Cava

Swedish Research Council

  • Felipe Cava

Kempe Foundation

  • Felipe Cava

Laboratory for Molecular Infection Medicine Sweden

  • Felipe Cava

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Vigouroux et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,209
    views
  • 714
    downloads
  • 112
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Antoine Vigouroux
  2. Baptiste Cordier
  3. Andrey Aristov
  4. Laura Alvarez
  5. Gizem Özbaykal
  6. Thibault Chaze
  7. Enno Rainer Oldewurtel
  8. Mariette Matondo
  9. Felipe Cava
  10. David Bikard
  11. Sven van Teeffelen
(2020)
Class-A penicillin binding proteins do not contribute to cell shape but repair cell-wall defects
eLife 9:e51998.
https://doi.org/10.7554/eLife.51998

Share this article

https://doi.org/10.7554/eLife.51998

Further reading

    1. Cell Biology
    Erli Jin, Jennifer K Briggs ... Matthew J Merrins
    Research Article

    Oscillations in insulin secretion, driven by islet Ca2+ waves, are crucial for glycemic control. Prior studies, performed with single-plane imaging, suggest that subpopulations of electrically coupled β-cells have privileged roles in leading and coordinating the propagation of Ca2+ waves. Here, we used three-dimensional (3D) light-sheet imaging to analyze the location and Ca2+ activity of single β-cells within the entire islet at >2 Hz. In contrast with single-plane studies, 3D network analysis indicates that the most highly synchronized β-cells are located at the islet center, and remain regionally but not cellularly stable between oscillations. This subpopulation, which includes ‘hub cells’, is insensitive to changes in fuel metabolism induced by glucokinase and pyruvate kinase activation. β-Cells that initiate the Ca2+ wave (leaders) are located at the islet periphery, and strikingly, change their identity over time via rotations in the wave axis. Glucokinase activation, which increased oscillation period, reinforced leader cells and stabilized the wave axis. Pyruvate kinase activation, despite increasing oscillation frequency, had no effect on leader cells, indicating the wave origin is patterned by fuel input. These findings emphasize the stochastic nature of the β-cell subpopulations that control Ca2+ oscillations and identify a role for glucokinase in spatially patterning ‘leader’ β-cells.

    1. Cell Biology
    Kelsey R Baron, Samantha Oviedo ... R Luke Wiseman
    Research Article

    Excessive mitochondrial fragmentation is associated with the pathologic mitochondrial dysfunction implicated in the pathogenesis of etiologically diverse diseases, including many neurodegenerative disorders. The integrated stress response (ISR) – comprising the four eIF2α kinases PERK, GCN2, PKR, and HRI – is a prominent stress-responsive signaling pathway that regulates mitochondrial morphology and function in response to diverse types of pathologic insult. This suggests that pharmacologic activation of the ISR represents a potential strategy to mitigate pathologic mitochondrial fragmentation associated with human disease. Here, we show that pharmacologic activation of the ISR kinases HRI or GCN2 promotes adaptive mitochondrial elongation and prevents mitochondrial fragmentation induced by the calcium ionophore ionomycin. Further, we show that pharmacologic activation of the ISR reduces mitochondrial fragmentation and restores basal mitochondrial morphology in patient fibroblasts expressing the pathogenic D414V variant of the pro-fusion mitochondrial GTPase MFN2 associated with neurological dysfunctions, including ataxia, optic atrophy, and sensorineural hearing loss. These results identify pharmacologic activation of ISR kinases as a potential strategy to prevent pathologic mitochondrial fragmentation induced by disease-relevant chemical and genetic insults, further motivating the pursuit of highly selective ISR kinase-activating compounds as a therapeutic strategy to mitigate mitochondrial dysfunction implicated in diverse human diseases.